Android Apple

Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week

By Yahoo! Finance   |   5 months ago
Nektar Therapeutics' (NASDAQ:NKTR) large institutional owners must be happy as stock continues to impress, up 13% over the past week

Institutional ownership of Nektar Therapeutics is over 50%, making stock price sensitive to their trading actions. Notable shareholders include Deep Track Capital, LP and The Vanguard Group, Inc., with a combined influence on board decisions.

Read More

Did you find this insightful?

close

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.